Journal of Diabetes Research
Scope & Guideline
Fostering collaboration for better diabetes outcomes.
Introduction
Aims and Scopes
- Diabetes Pathophysiology and Mechanisms:
Research exploring the underlying biological mechanisms of diabetes, including insulin resistance, beta-cell dysfunction, and genetic factors influencing disease progression. - Clinical Management and Treatment Strategies:
Studies evaluating various treatment modalities for diabetes, including pharmacological interventions, lifestyle modifications, and emerging therapies such as GLP-1 receptor agonists and SGLT-2 inhibitors. - Diabetes Complications:
Research focused on the complications associated with diabetes, such as cardiovascular disease, diabetic retinopathy, nephropathy, and neuropathy, and their management. - Public Health and Epidemiology:
Investigations into the epidemiology of diabetes, including prevalence, risk factors, and the impact of diabetes on public health, particularly in diverse populations. - Innovative Technologies in Diabetes Management:
Studies that assess the application of new technologies, such as continuous glucose monitoring and telemedicine, in improving diabetes care and patient outcomes. - Nutritional and Lifestyle Interventions:
Research examining the role of diet, physical activity, and behavioral interventions in diabetes prevention and management. - Integrative and Traditional Medicine Approaches:
Exploration of complementary and alternative medicine approaches, including traditional Chinese medicine, in the treatment of diabetes.
Trending and Emerging
- Diabetes and COVID-19 Interactions:
Research examining the relationship between diabetes and COVID-19, including the impact of diabetes on disease severity and outcomes, has gained significant traction in response to the pandemic. - Precision Medicine and Genomics:
Studies focusing on the genetic and genomic aspects of diabetes, including personalized medicine approaches that tailor treatment based on individual genetic profiles, are increasingly prevalent. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting diabetes outcomes, optimizing treatment regimens, and enhancing patient monitoring is an emerging area of focus, reflecting the integration of technology in healthcare. - Behavioral Health and Diabetes Distress:
There is a growing emphasis on the psychological aspects of diabetes management, including diabetes distress and the impact of mental health on treatment adherence and outcomes. - Microbiome and Diabetes:
Research exploring the gut microbiome's role in diabetes pathogenesis and management is on the rise, highlighting the importance of microbiota in metabolic health. - Telemedicine and Remote Patient Monitoring:
The advancement and implementation of telehealth solutions for diabetes management have gained momentum, especially post-pandemic, emphasizing the need for accessible healthcare solutions.
Declining or Waning
- Basic Science Research:
There has been a noticeable decrease in basic science studies that solely focus on cellular and molecular mechanisms of diabetes without direct clinical implications. This shift may be due to an increasing emphasis on translational research that bridges laboratory findings with clinical applications. - Historical Epidemiological Studies:
Research that reviews historical data or trends in diabetes prevalence and outcomes appears to be waning. This could be attributed to a shift towards more contemporary, real-time data analysis and the need for immediate applicability in clinical settings. - Pharmacotherapy Comparisons:
Comparative studies of older diabetes medications are becoming less frequent as newer agents and combination therapies gain prominence in diabetes management discussions. - Conventional Dietary Interventions:
Studies focusing solely on traditional dietary interventions without incorporating modern nutritional science or technology are becoming less common, as there's a trend towards personalized nutrition and integrative approaches.
Similar Journals
British Journal of Diabetes
Connecting researchers and practitioners for diabetes advancement.The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.
Diabetologie und Stoffwechsel
Pioneering Research in Endocrinology and Metabolic DisordersDiabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.
ACTA DIABETOLOGICA
Fostering Breakthroughs in Metabolic HealthACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.
BMJ Open Diabetes Research & Care
Transforming diabetes management with peer-reviewed insights.BMJ Open Diabetes Research & Care is a premier open access journal published by the BMJ PUBLISHING GROUP, dedicated to advancing the field of diabetes research and care. With an impressive impact factor and positioned in the Q1 category of Endocrinology, Diabetes and Metabolism, this journal serves as a vital resource for researchers, clinicians, and healthcare professionals striving to improve diabetes management and treatment strategies. Since its inception in 2014, the journal has provided an accessible platform for high-quality, peer-reviewed research, ensuring global outreach and dissemination of groundbreaking findings in diabetes care. With Scopus ranking it at #35 out of 244 in its field, reflecting an 85th percentile ranking, BMJ Open Diabetes Research & Care remains committed to fostering innovation and discourse within the diabetes community. This journal not only publishes original research articles but also invites systematic reviews, clinical studies, and comprehensive reviews, aiming to address the pressing challenges faced in diabetes care today.
Diabetes Therapy
Empowering healthcare with groundbreaking therapeutic strategies.Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.
Journal of Diabetes
Advancing diabetes research for a healthier tomorrow.The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.
CURRENT DIABETES REVIEWS
Fostering Collaboration in Diabetes ResearchCURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.
DIABETES-METABOLISM RESEARCH AND REVIEWS
Elevating Knowledge in Endocrinology and MetabolismDIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.
Diabetes Mellitus
Exploring the complexities of diabetes and its impact.Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.
Diabetology International
Advancing diabetes research for a healthier tomorrow.Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.